2024 Update for Complex Non-Sterile Compounding: USP <795> and Pharmaceutical Calculations
This presentation focuses on the latest version of USP <795>, delving into key revisions and updates. Participants will be able to identify and explain these changes, and understand the guidelines for determining beyond-use dates in non-sterile preparations. They will be equipped to design a comprehensive training program encompassing essential aspects of non-sterile compounding practices. By the end of the presentation, participants will be proficient in selecting and justifying components suitable for non-sterile compounding based on formulation requirements. The inclusion of mathematical concepts and pharmaceutical calculations ensures that participants leave with the skills needed for accurate preparation of non-sterile compounded formulations.
Learning ObjectivesUpon completion of this activity, the participant should be able to:
- Identify and explain the key revisions and updates in the latest version of USP <795>
- Evaluate and apply guidelines from USP <795> to determine the beyond-use date for non-sterile preparations
- Design a comprehensive training program that covers essential aspects of non-sterile compounding practices
- Identify and justify the selection of components suitable for non-sterile compounding based on formulation requirements
- Apply mathematical concepts and pharmaceutical calculations to ensure accurate preparation of non-sterile compounded formulations
Presenter
Omar Allibhai, PharmD, RPh, FACA, FAPC a licensed pharmacist at Johnson Compounding & Wellness. He holds the distinction of being the first pharmacist to complete a groundbreaking two-year post-doctoral fellowship in pharmacy compounding nationwide. He received his PharmD and a certificate in radiopharmacy from MCPHS.
In his multifaceted role, Omar oversees diverse aspects of the pharmacy operation, including non-sterile compounding, formulation development, employee training, and the implementation of quality assurance programs.
He is a member of professional associations including the Massachusetts Independent Pharmacists Association, Massachusetts Pharmacist Association, Alliance for Pharmacy Compounding, American College of Apothecaries, and Johnson Compounding and Wellness's Quality Assurance team.
Registration Fee: Free for MCPHS alumni, full-time staff, and $12 for all other professionals.
Release Date: June 7, 2024
Expiration Date: June 6, 2025
ACPE UAN: 0026-0000-24-015-H04-P | Knowledge
ACPE Topic Designator: Pharmacy Law
Contact Hours: 1.5 (0.15 CEU)
Our CE is considered for both compounding credit and law in Massachusetts. The compounding modules are designated as law (03); however, they count for compounding (07) as well due to the titling and learning objectives as indicated in MA BOP Policy 2021-04: Continuing Education (CE) Requirements [PDF].
CE programs that cover the regulatory component of compounding are acceptable to fulfill the requirement for both compounding and law contact hours as long as the regulatory component is approved as a “law” CE program and the compounding component meets the acceptable program criteria set forth above.
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1.5 contact hours (0.15 CEUs).
To receive credit, participants must complete pre and post-assessments, view the entire presentation, and evaluate the session. Participant credit will be reported to the CPE Monitor upon conclusion. Transcripts may be printed from the CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Omar Allibhai has no financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry is provided for this event. No exhibitors will be present.